Amarin Corp Plc (AMRN)

[FlyFishingStocks]

AMRN got greedy before the ANCHOR Adcom by making the claim that lowering trigs prevented CVD. The FDA deemed that claim too inconclusive and crushed the idea/indication.
Now, just before results were unveiled, they got greedy again and added 30 more endpoints in hopes of ‘raising the bar’ to extend the trial and allow more separation between the two arms. In the process, they missed a great opportunity to make a big splash, halt the trial, crush shorts, offer the company for a buyout, and get the drug into as many hands, as quickly as possible. Oh well, once again the investor is left holding the bag of dead money.
No matter how you sugar coat it, everything has changed, the dream is gone and sadly, the volcano has gone silent. For years we were led to believe that a small band of brains knew something the whole market did not, and that such a discovery was the very secret behind Jesse Livermore’s success as an investor.
So what might we expect over the next 8 months while awaiting the next interim?
How about political/world turmoil, surging volatility and a nasty bear market that takes no prisoners? If such conditions develop, how will AMRNs pps hold up? Will buyers continue to support a risky, small cap speculative company expecting an additional look to see if just 10% more events can suddenly boost all endpoints to become efficacious? What about all those new converted shareholders? What happens if their shares suddenly slip underwater? Would they sell these shares as part of their tax loss selling requirements?
IMO, all things considered, I think the recent announcement has severely increased the risk / reward ratio of this investment and has inhibited the likelihood of any run up for a repeat. Finally,.. it is time to move on. ARIA anyone?
GLTA,
FFS